Verition Fund Management
SPRB

Verition Fund Management’s Spruce Biosciences SPRB Stock Holding History

Verition Fund Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,592
Closed -$2.98M – 2736
2023
Q3 		$2.98M Buy
17,592
+3,142
+22% +$530K 0.03% 633
2023
Q2 		$2.33M Buy
14,450
+1,625
+13% +$272K 0.03% 618
2023
Q1 		$2.13M Buy
+12,825
New +$2.38M 0.03% 681

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Verition Fund Management's SPRB Position: Q4 2023 in Review

Verition Fund Management sold out of Spruce Biosciences (SPRB) in Q4 2023, closing a stake of 17,592 shares — an estimated $2.98M sold.

Verition Fund Management first reported a position in SPRB in Q1 2023 and held it in 3 quarters. The position peaked at $2.98M in Q3 2023. 37 funds tracked by Wall St. Rank hold SPRB as of Q4 2023.

  • Verition Fund Management reported no remaining Spruce Biosciences position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 17,592 Spruce Biosciences shares in Q4 2023, an estimated $2.98M.
  • Verition Fund Management first reported a position in Spruce Biosciences in Q1 2023 and held it in 3 quarters.
  • Verition Fund Management's Spruce Biosciences position peaked at $2.98M in Q3 2023.
  • 37 funds tracked by Wall St. Rank held Spruce Biosciences as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.